DAIsy

Major depressive disorder (MDD) is a common psychiatric disorder, ranking as the second leading contributor of years lived with disability. Finding the right approach for individual patients remains challenging. DAIsy will develop and bring to the market AI-supported solutions for improved diagnosis, treatment selection, diet monitoring, activity tracking, support in behaviour adjustments, and treatment response assessment. Novel AI techniques will be jointly developed to advance the AI applicability for these fragile patients by advancing techniques for large data points/patient ratios, improving explainability and uncertainty quantification.